TEVA FY 2015 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$36B

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$19.7B-3.1% YoY

Gross Profit

$11.4B57.8% margin

Operating Income

$3.4B17.1% margin

Net Income

$1.6B8.1% margin

EPS (Diluted)

$1.82

Cash Flow

Operating Cash Flow

$5.5B

Free Cash Flow

$4.8B

Stock-Based Comp.

$117M

Balance Sheet

Total Assets

$54.3B

Total Liabilities

$24.3B

Stockholders' Equity

$29.8B

Cash & Equivalents

$6.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19.7B	$20.3B	-3.1%
Gross Profit	$11.4B	$11.1B	+2.7%
Operating Income	$3.4B	$4.0B	-15.2%
Net Income	$1.6B	$3.1B	-48.0%